A study on the incidence of micro-albuminurea and left ventricular hypertrophy among hypertensive patients

Abstract

Background: Hypertension provides both despair and hope. Despair because it is quantitatively the largest risk factor for cardiovascular diseases,
is growing in prevalence, and is poorly controlled virtually everywhere. Hope because prevention is possible and because treatment can control
hypertension in all most all patients with consequent marked reduction in stroke and heart attack. Aim of study: To find out the incidence of
micro-albuminuria and left ventricular hypertrophy among hypertensive patients without associated conditions like diabetes mellitus, stroke,
ischaemic heart disease and renal diseases. Materials and methods: The Study was conducted in 97 cases who are hospitalized in Alluri
Sitarama Raju Academy of Medical Sciences from October 2020 to October 2021. after getting approved by the institutional ethical committee.
An individual informed consent is taken from all the patients selected for the study. Discussion: Left ventricular hypertrophy and
microalbuminuria are currently drawing a great deal of attention in the medical literature. Much of this attention derives from the fact that
albumin excretion is a risk factor for kidney failure, stroke, and cardiovascular and all cause mortality, particularly for persons with hypertension.
Conclusion: In our study 22.7 % of the study subjects had microalbuminuria and 20.6 % had left ventricular hypertrophy.